Ribbon-cutting ceremony and open house to take place today with local officials.
ALAMEDA, CA – 31 July, 2017 – AllCells, LLC, today announced the official opening of its Quincy, MA tissue collection facilities, known as Leukolab, located at 500 Congress Street, Ste 1-A, Quincy, MA. The new site marks AllCells’ second LeukoLab cell collection facility based in the U.S.
The new 4,000 square foot facility is staffed with Apheresis RNs, Phlebotomists, and licensed physicians who carry out IRB-approved tissue collection protocols on healthy donors. Our Donor Management Team ensures that donors are screened, qualified, and scheduled for collections according to regulatory and customer requirements, and that all donors undergo a safe, pleasant donation experience.
Quincy, MA LeukoLab operations now offers healthy donor whole blood, whole bone marrow, and non-mobilized and mobilized donor (Filgrastim and/or Plerixafor) apheresis products with same-day fresh product delivery to life science researchers located in the Boston/Cambridge area, and next-day delivery across the US East Coast.
Today’s ribbon cutting event included Thomas P. Koch, the Honorable Mayor of Quincy, along with Tim Cahill, President and Executive Director of the Quincy Chamber of Commerce, and local customers. AllCells representatives included Hassan Saleem, General Manager AllCells-Quincy, Rob Frankenberg, VP Manufacturing Operations, Afshin Shirazian, Sr. Manager Marketing, and Jay Tong, Founder and President/CEO of AllCells (shown below). The event included a reception, brief remarks, official ribbon cutting, and open house.
“On behalf of the Commonwealth, I welcome AllCells to Massachusetts,” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. “This new facility will further Massachusetts’ position as the best place for life sciences resources, world-class research, and patient care. I look forward to working with AllCells to ensure their presence in Massachusetts is not only beneficial to them but to industry stakeholders as well.”
About AllCells, LLC
AllCells is a biotechnology company dedicated to providing researchers and biomanufacturing organizations with high quality primary cells that enable drug discovery, preclinical development, and manufacturing of cell therapies. Leveraging its expertise in hematopoietic and immune cell isolation and characterization together with on-site hematologic tissue clinical collection operations, AllCells maintains a large repository of donor profiles that can be qualified for various biomedical applications. Freshly collected tissue is immediately processed in contiguous manufacturing facilities to produce purified cell types having unparalleled quality and consistency. Cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays (AllCellutions™) custom designed according to customer criteria. For more information, please visit www.allcells.com.
Wayne E. Vaz, VP, Corporate Development
AllCells, LLC, P (510) 671-8676